The diagnostic ultrasound market saw 5% growth in per-site volume in hospital radiology units in 1998, according to the latest Technology Marketing Group report, published last month. The TMG Diagnostic Ultrasound Census, conducted in
The diagnostic ultrasound market saw 5% growth in per-site volume in hospital radiology units in 1998, according to the latest Technology Marketing Group report, published last month. The TMG Diagnostic Ultrasound Census, conducted in cooperation with the American Institute for Ultrasound in Medicine, found that ultrasound procedures in the U.S. last year totaled 14.7 million in 1875 hospital radiology sites of more than 200 beds. At least 42% of these sites expect to buy new equipment in the next three years, and average procedure volume per ultrasound device is 2350 procedures. Des Plaines, IL-based TMGs report covered about one-third of the sites and installed units in the U.S.
Leading Breast Radiologists Discuss the USPSTF Breast Cancer Screening Recommendations
May 17th 2024In recognition of National Women’s Health Week, Dana Bonaminio, MD, Amy Patel, MD, and Stacy Smith-Foley, MD, shared their thoughts and perspectives on the recently updated breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF).
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Appealing Prior Authorization Denials: Can it be Effective for Emerging Technologies?
May 14th 2024While radiologists and other providers may be discouraged by insurer denials saying the use of a technological advance is “unproven and investigational,” 82 percent of appeals for prior authorization denials were approved in 2021.
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.